In this review, we provide a concise overview of neoadjuvant systemic therapy in early-stage HER2-positive breast cancer, with a focus on various chemotherapy backbones and de-escalation strategies.

Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor Biology. If you have the appropriate software installed, you can download article ...

persevERA is the first of two distinct Phase III studies in the first-line setting; the pionERA study of giredestrant in combination with physician’s choice of cyclin-dependent kinase (CDK)4/6 ...

Recent studies have further advanced our understanding of MFG-E8 using innovative approaches and state-of-the-art methodologies. An investigation employing spherical nucleic acid nanoparticle ...

For permission requests, please contact NEJM Reprints at [email protected] Select the format you want to export the citation of this publication.

A global team of researchers has made a groundbreaking discovery that saves the lives of patients suffering from toxic epidermal necrolysis. This rare but often fatal reaction to common medications ...